Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Dapagliflozin reduces systemic inflammation in patients with type 2 diabetes without known heart failure.

  • Authors : Wang DD; Division of Cardiology, Department of Medicine, University of Washington, Seattle, WA, USA.; Naumova AV

Subjects: Benzhydryl Compounds*/Benzhydryl Compounds*/Benzhydryl Compounds*/therapeutic use ; Benzhydryl Compounds*/Benzhydryl Compounds*/Benzhydryl Compounds*/adverse effects ; Glucosides*/Glucosides*/Glucosides*/therapeutic use

  • Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Jun 07; Vol. 23 (1), pp. 197. Date of Electronic Publication: 2024 Jun 07.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

Record details

×
  • 1-10 of  1,217 results for ""Respiration""